Bruton Tyrosine Kinase (BTK) inhibitor

News

An early-stage drug that is being developed to tackle inflammatory and autoimmune diseases has been approved by the US regulator.

News

Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.